Newsroom

#ACR19 has come to an end but we remain dedicated to continuing the important dialogue on patient burden associated with axial spondyloarthritis. #axSpA #rheumatology https://t.co/Uh621a76We

#Antibodies could help combat #neurodegenerativediseases, even potentially halt brain cell degeneration. Take a peek at our research: https://t.co/CCqlMycwJG https://t.co/BEUCHKlzhz

Patients with non-radiographic axial spondyloarthritis report substantial impairment in household productivity and daily activities due to disease burden. We are committed to raising the standard of care for people living with chronic #rheumatic diseases. #ACR19 https://t.co/gKezkiFi66

#DYK #atopicdermatitis & #psoriasis affect 300 million people worldwide. Read how @BIOMAP-IMI hopes to pave the way for a more individualized approach to therapy. https://t.co/L4ZRU7hbBK #InspiredByPatients #DrivenByScience https://t.co/NIjY5ry4u3